Induction Therapy for Lupus Nephritis: the Highlights
- Current Rheumatology Reports
Authors: Isabelle Ayoub, Jessica Nelson, Brad H. Rovin
Publisher: Springer US
Purpose of Review
Lupus nephritis is a frequent complication of systemic lupus erythematosus and is more common and severe in children. This is a disease of the immune system characterized by T cell, B cell, and complement activation, as well as immune complex formation and deposition. The introduction of steroids and later cyclophosphamide transformed lupus nephritis from a fatal to a treatable condition. However, the standard therapies currently used for treatment carry significant toxicity and chronic kidney disease still remains a far too frequent outcome. To address these issues, we will review current and emerging induction therapies in LN.
Several clinical trials have been undertaken to test more effective and safer drugs, often targeting mechanistic disease pathways.
At present, it is difficult to identify an induction regimen that is more effective and less toxic than the standard of care; however, we believe continuing efforts in drug development will bring breakthrough agents to clinics.